Tata India Pharma & Healthcare Fund-Direct Plan-Growth
Benchmark: BSE Healthcare TRI · Riskometer: Very High
₹40.047
NAV (2026-08-31)
₹1,565.28 Cr
AUM (2026-08-31)
0.97%
EXPENSE RATIO (DIRECT)
2015-12-04
INCEPTION
Punji Fund Health Score - percentile-within-category. See methodology.
CHART
Rolling CAGR by holding period - min, median, max
Each group is one holding-period length. Full range of outcomes across every overlapping window in the fund's history, not one trailing number.
| Metric | Value | Percentile | Category median |
|---|---|---|---|
| 3Y Rolling CAGR | 21.3% | 80.58th | 17.5% |
| 3Y Sharpe Ratio | 1.01 | 86.49th | 0.63 |
| 3Y Alpha | -0.9% | 15.45th | 2.7% |
| 3Y Std Deviation | 14.1% | 63.06th (lower is better) | 15.0% |
1.0082
1.5223
-0.8601
0.9057
14.1481
-16.8059
90.3704
90.3917
4.134
Tracking Error (%)
1.2588
3-year window vs. BSE Healthcare TRI.
CHART
Top sector holdings
Share of portfolio (% to NAV) in each of the top sectors.
TOP HOLDINGS
Funds that behave most similarly (beta, capture ratios, volatility - not holdings overlap). Pick up to 2 to compare alongside this fund:
CHART
Asset Allocation
As of Jul-2026
CHART
Market Cap Split
As of Jul-2026
Portfolio analytics as of Jul-2026.
Data as of 2026-09-02. Source: AMFI disclosures via Punji. Not investment advice.